FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312173686> ?p ?o ?g. }

• W4312173686 endingPage "211" @default.
• W4312173686 startingPage "211" @default.
• W4312173686 abstract "Antiphospholipid antibodies (aPL) comprise a group of autoantibodies that reflect prothrombotic risk in antiphospholipid syndrome (APS) but may also be present in a small proportion of healthy individuals. They are often transiently elevated in infections, including SARS-CoV-2, and may also be associated with vaccine-induced autoimmunity. Therefore, we aimed to investigate the dynamics of aPL in COVID-19 patients and in individuals (healthcare professionals-HCPs) after receiving BNT162b2 vaccine and to compare aPL levels and positivity with those found in APS patients. We measured solid-phase identifiable aPL, including anticardiolipin (aCL), anti-β2 glycoprotein I (anti-β2GPI), and anti-prothrombin/phosphatidylserine (aPS/PT) antibodies in 58 HCPs before and after vaccination (at 3 weeks, 3, 6, and 9 months after the second dose, and 3 weeks after the third booster dose), in 45 COVID-19 patients hospitalized in the ICU, in 89 COVID-19 patients hospitalized in the non-ICU (at admission, at hospital discharge, and at follow-up), and in 52 patients with APS. The most frequently induced aPL in COVID-19 patients (hospitalized in non-ICU) were aCL (50.6% of patients had positive levels at at least one time point), followed by anti-β2GPI (21.3% of patients had positive levels at at least one time point). In 9/89 COVID-19 patients, positive aPL levels persisted for three months. One HCP developed aCL IgG after vaccination but the persistence could not be confirmed, and two HCPs developed persistent anti-β2GPI IgG after vaccination with no increase during a 1-year follow-up period. Solid-phase aPL were detected in 84.6% of APS patients, in 49.4% of COVID-19 patients hospitalized in the non-ICU, in 33.3% of COVID-19 patients hospitalized in the ICU, and in only 17.2% of vaccinated HCPs. aPL levels and multiple positivity were significantly lower in both infected groups and in vaccinated individuals compared with APS patients. In conclusion, BNT162b2 mRNA vaccine may have induced aPL in a few individuals, whereas SARS-CoV-2 infection itself results in a higher percentage of aPL induction, but the levels, persistence, and multiple positivity of aPL do not follow the pattern observed in APS." @default.
• W4312173686 created "2023-01-04" @default.
• W4312173686 creator A5008407790 @default.
• W4312173686 creator A5048610469 @default.
• W4312173686 creator A5049082809 @default.
• W4312173686 creator A5059007137 @default.
• W4312173686 creator A5060748260 @default.
• W4312173686 creator A5063830434 @default.
• W4312173686 creator A5065649694 @default.
• W4312173686 creator A5076015597 @default.
• W4312173686 creator A5084185428 @default.
• W4312173686 creator A5087803133 @default.
• W4312173686 creator A5087971948 @default.
• W4312173686 date "2022-12-22" @default.
• W4312173686 modified "2023-10-16" @default.
• W4312173686 title "Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2" @default.
• W4312173686 cites W1975074770 @default.
• W4312173686 cites W1977734133 @default.
• W4312173686 cites W2006382093 @default.
• W4312173686 cites W2007123966 @default.
• W4312173686 cites W2014479232 @default.
• W4312173686 cites W2037965327 @default.
• W4312173686 cites W2054330426 @default.
• W4312173686 cites W2104266044 @default.
• W4312173686 cites W2105737018 @default.
• W4312173686 cites W2171218882 @default.
• W4312173686 cites W2514998251 @default.
• W4312173686 cites W2580707222 @default.
• W4312173686 cites W2752622099 @default.
• W4312173686 cites W2887943084 @default.
• W4312173686 cites W2901874447 @default.
• W4312173686 cites W3008827533 @default.
• W4312173686 cites W3012421327 @default.
• W4312173686 cites W3014573995 @default.
• W4312173686 cites W3035618713 @default.
• W4312173686 cites W3035882439 @default.
• W4312173686 cites W3037361899 @default.
• W4312173686 cites W3039804972 @default.
• W4312173686 cites W3041374361 @default.
• W4312173686 cites W3046781522 @default.
• W4312173686 cites W3087116551 @default.
• W4312173686 cites W3092459053 @default.
• W4312173686 cites W3094906854 @default.
• W4312173686 cites W3111255098 @default.
• W4312173686 cites W3111642148 @default.
• W4312173686 cites W3112078636 @default.
• W4312173686 cites W3118590900 @default.
• W4312173686 cites W3121259291 @default.
• W4312173686 cites W3121359554 @default.
• W4312173686 cites W3157571221 @default.
• W4312173686 cites W3157578989 @default.
• W4312173686 cites W3172713040 @default.
• W4312173686 cites W3184492194 @default.
• W4312173686 cites W3185045052 @default.
• W4312173686 cites W4206104577 @default.
• W4312173686 cites W4213183079 @default.
• W4312173686 cites W4225125072 @default.
• W4312173686 cites W4225960124 @default.
• W4312173686 cites W4280606414 @default.
• W4312173686 cites W4281643894 @default.
• W4312173686 cites W4281944362 @default.
• W4312173686 cites W4283277302 @default.
• W4312173686 cites W4285590399 @default.
• W4312173686 cites W4292162724 @default.
• W4312173686 cites W4299878932 @default.
• W4312173686 cites W4300962756 @default.
• W4312173686 cites W4308291803 @default.
• W4312173686 cites W50490408 @default.
• W4312173686 doi "https://doi.org/10.3390/ijms24010211" @default.
• W4312173686 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36613655" @default.
• W4312173686 hasPublicationYear "2022" @default.
• W4312173686 type Work @default.
• W4312173686 citedByCount "1" @default.
• W4312173686 countsByYear W43121736862023 @default.
• W4312173686 crossrefType "journal-article" @default.
• W4312173686 hasAuthorship W4312173686A5008407790 @default.
• W4312173686 hasAuthorship W4312173686A5048610469 @default.
• W4312173686 hasAuthorship W4312173686A5049082809 @default.
• W4312173686 hasAuthorship W4312173686A5059007137 @default.
• W4312173686 hasAuthorship W4312173686A5060748260 @default.
• W4312173686 hasAuthorship W4312173686A5063830434 @default.
• W4312173686 hasAuthorship W4312173686A5065649694 @default.
• W4312173686 hasAuthorship W4312173686A5076015597 @default.
• W4312173686 hasAuthorship W4312173686A5084185428 @default.
• W4312173686 hasAuthorship W4312173686A5087803133 @default.
• W4312173686 hasAuthorship W4312173686A5087971948 @default.
• W4312173686 hasBestOaLocation W43121736861 @default.
• W4312173686 hasConcept C126322002 @default.
• W4312173686 hasConcept C159654299 @default.
• W4312173686 hasConcept C203014093 @default.
• W4312173686 hasConcept C22070199 @default.
• W4312173686 hasConcept C2776874634 @default.
• W4312173686 hasConcept C2779134260 @default.
• W4312173686 hasConcept C2780022809 @default.
• W4312173686 hasConcept C3008058167 @default.
• W4312173686 hasConcept C524204448 @default.
• W4312173686 hasConcept C71924100 @default.
• W4312173686 hasConceptScore W4312173686C126322002 @default.

• next